Adalimumab treatment for psoriasis - safety in numbers

被引：0
|
作者：
Fleming, P. [1 ]
机构：
[1] Lynde Inst Dermatol, 5 Washington St, Markham, ON L3P 2R3, Canada
来源：
BRITISH JOURNAL OF DERMATOLOGY | 2019年 / 180卷 / 01期
关键词：
EFALIZUMAB; MODERATE;
D O I：
10.1111/bjd.17322
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
收藏
页码：14 / 15
页数：2
相关论文
共 50 条
  • [31] Safety and tolerability of adalimumab for the treatment of psoriasis: a review summarizing 15 years of real-life experience
    Sator, Paul
    THERAPEUTIC ADVANCES IN CHRONIC DISEASE, 2018, 9 (08) : 147 - 158
  • [32] Safety and efficacy of Adalimumab in the treatment of moderate to severe palmo-plantar psoriasis: an open label study
    Richetta, A. G.
    Mattozzi, C.
    Giancristoforo, S.
    D'Epiro, S.
    Cantisani, C.
    Macaluso, L.
    Salvi, M.
    Calvieri, S.
    CLINICA TERAPEUTICA, 2012, 163 (02): : E61 - E66
  • [33] Comparative effectiveness of adalimumab versus ustekinumab treatment for psoriasis: Clinical efficacy, safety, and cost per responder
    Wu, Eric
    Signorovitch, James
    Mulani, Parvez
    Bao, Yanjun
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2010, 62 (03) : AB125 - AB125
  • [34] Topical Treatment Habits in Psoriasis Patients Receiving Adalimumab
    Kolios, A. G. A.
    Rusca, F.
    Reisenbauer, K.
    Cozzio, A.
    French, L. E.
    Navarini, A. A.
    DERMATOLOGY, 2012, 224 (03) : 228 - 230
  • [35] Marked Improvement in Nail Psoriasis during Treatment with Adalimumab
    Irla, N.
    Yawalkar, N.
    DERMATOLOGY, 2009, 219 (04) : 353 - 356
  • [36] Treatment of erythrodermic psoriasis in HCV plus patient with adalimumab
    Richetta, Antonio Giovanni
    Maiani, Elisa
    Carlomagno, Valentina
    Carboni, Valentina
    Mattozzi, Carlo
    Giancristoforo, Simona
    Calvieri, Stefano
    DERMATOLOGIC THERAPY, 2009, 22 : S16 - S18
  • [37] PSORIASIS FLARE WITH ADALIMUMAB USE FOR PSORIATIC ARTHRITIS TREATMENT
    Arora, Anandita
    Elkhider, Alaa
    Mohamed, Mohamed
    Kadhim, Ahmed
    Maroun, Marie-Claim
    JOURNAL OF GENERAL INTERNAL MEDICINE, 2017, 32 : S571 - S571
  • [38] Adalimumab treatment for severe recalcitrant chronic plaque psoriasis
    Ryan, C.
    Kirby, B.
    Collins, P.
    Rogers, S.
    CLINICAL AND EXPERIMENTAL DERMATOLOGY, 2009, 34 (07) : 784 - 788
  • [39] Adalimumab for treatment of moderate to severe psoriasis and psoriatic arthritis
    Bongiorno, M. R.
    Pistone, G.
    Doukaki, S.
    Arico, M.
    DERMATOLOGIC THERAPY, 2008, 21 : S15 - S20
  • [40] Topical treatment habits in psoriasis patients receiving adalimumab
    Kolios, Antonios
    Rusca, Francisca
    Reisenbauer, Karin
    French, Lars
    Navarini, Alexander
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2011, 131 : S40 - S40
12345